Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?

Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology

(2018) David J. Potter et al.   Drug Testing and Analysis

Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods

(2018) Krista M. Lisdahl et al.   Developmental Cognitive Neuroscience

Keep off the grass? Cannabis, cognition and addiction

(2016) H. Valerie Curran et al.   NATURE REVIEWS NEUROSCIENCE

Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis

(2016) Arianna Marconi et al.   SCHIZOPHRENIA BULLETIN

Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males

(2016) C Mokrysz et al.   Translational Psychiatry

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers

(2016) C J A Morgan et al.   Translational Psychiatry

Hippocampal harms, protection and recovery following regular cannabis use

(2016) M Yücel et al.   Translational Psychiatry

Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom

(2015) Chandni Hindocha et al.   DRUG AND ALCOHOL DEPENDENCE

Examining the profile of high-potency cannabis and its association with severity of cannabis dependence

(2015) T. P. Freeman et al.   PSYCHOLOGICAL MEDICINE

Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013

(2015) Deborah S. Hasin et al.   JAMA Psychiatry

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study

(2014) Peggy van der Pol et al.   ADDICTION

Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

(2014) Tom P. Freeman et al.   ADDICTION

Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users

(2013) M. Di Forti et al.   SCHIZOPHRENIA BULLETIN

Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users

(2012) Marta Di Forti et al.   BIOLOGICAL PSYCHIATRY

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

(2012) Amir Englund et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

(2011) C. J. A. Morgan et al.   PSYCHOLOGICAL MEDICINE

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

(2010) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

(2008) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

(2008) JG Ramaekers et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

(2008) Deepak Cyril D'Souza et al.   NEUROPSYCHOPHARMACOLOGY

The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis

(2008) Oliver J. Mason et al.   SCHIZOPHRENIA RESEARCH